Search research articles
Contact Us
Filters
Showing results (81-90 of 171) with videos related to
Page
of 18
Sort By:
International Immunopharmacology
|
July 25, 2024
RNA modification Regulators' Co-Expression Score (RMRCoeS) predicts biochemical recurrence and therapy response in prostate cancer: A multi-omics and experimental validation study
Zhouda Cai, Zhaojun Jiang, Songbo Li, et al.
Molecular Therapy. Oncology
|
April 17, 2025
Phosphoribosyl transferase domain containing 1: A prognostic biomarker in testicular germ cell tumors
Peisheng Huang, Yihao Chen, Yongcheng Shi, et al.
Acta Biochimica Et Biophysica Sinica
|
May 19, 2025
Integrated multi-omics and experimental approaches identify fascin actin-bundling protein 1 as an unfavorable prognostic biomarker in adrenocortical carcinoma
Pingkaiqi He, Yihao Chen, Ming Xi, et al.
International Journal of Molecular Sciences
|
October 7, 2020
Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models
Sang-In Kim, Shyambabu Chaurasiya, Anthony K Park, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 9, 2025
CF33-hNIS-antiPDL1 enhances immunogenicity and anti-tumor efficacy in an orthotopic syngeneic pancreatic cancer mouse model
Zhifang Zhang, Annie Yang, Anthony K Park, et al.
Seminars in Oncology
|
December 3, 2025
Submicron silica particles drives prostate cancer aggressiveness via lipid-metabolic reprogramming
Pengpeng Su, Qianfeng Xu, Yan Wang, et al.
Physiological Genomics
|
March 22, 2012
Application of a homogenous membrane potential assay to assess mitochondrial function
Srilatha Sakamuru, Xiao Li, Matias S Attene-Ramos, et al.
Annals of Medicine
|
December 3, 2024
Multi-omics profiling highlights karyopherin subunit alpha 2 as a promising biomarker for prognosis and immunotherapy respond in pediatric and adult adrenocortical carcinoma
Yihao Chen, Shumin Fang, Chuanfan Zhong, et al.
Frontiers in Cell and Developmental Biology
|
December 28, 2020
An Eight-CircRNA Assessment Model for Predicting Biochemical Recurrence in Prostate Cancer
Shuo Wang, Wei Su, Chuanfan Zhong, et al.
Journal of the American College of Surgeons
|
February 8, 2020
Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer
Yanghee Woo, Zhifang Zhang, Annie Yang, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 171) with videos related to
Sort By:
Page
of 18
International Immunopharmacology
|
July 25, 2024
RNA modification Regulators' Co-Expression Score (RMRCoeS) predicts biochemical recurrence and therapy response in prostate cancer: A multi-omics and experimental validation study
Zhouda Cai, Zhaojun Jiang, Songbo Li, et al.
Molecular Therapy. Oncology
|
April 17, 2025
Phosphoribosyl transferase domain containing 1: A prognostic biomarker in testicular germ cell tumors
Peisheng Huang, Yihao Chen, Yongcheng Shi, et al.
Acta Biochimica Et Biophysica Sinica
|
May 19, 2025
Integrated multi-omics and experimental approaches identify fascin actin-bundling protein 1 as an unfavorable prognostic biomarker in adrenocortical carcinoma
Pingkaiqi He, Yihao Chen, Ming Xi, et al.
International Journal of Molecular Sciences
|
October 7, 2020
Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models
Sang-In Kim, Shyambabu Chaurasiya, Anthony K Park, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 9, 2025
CF33-hNIS-antiPDL1 enhances immunogenicity and anti-tumor efficacy in an orthotopic syngeneic pancreatic cancer mouse model
Zhifang Zhang, Annie Yang, Anthony K Park, et al.
Seminars in Oncology
|
December 3, 2025
Submicron silica particles drives prostate cancer aggressiveness via lipid-metabolic reprogramming
Pengpeng Su, Qianfeng Xu, Yan Wang, et al.
Physiological Genomics
|
March 22, 2012
Application of a homogenous membrane potential assay to assess mitochondrial function
Srilatha Sakamuru, Xiao Li, Matias S Attene-Ramos, et al.
Annals of Medicine
|
December 3, 2024
Multi-omics profiling highlights karyopherin subunit alpha 2 as a promising biomarker for prognosis and immunotherapy respond in pediatric and adult adrenocortical carcinoma
Yihao Chen, Shumin Fang, Chuanfan Zhong, et al.
Frontiers in Cell and Developmental Biology
|
December 28, 2020
An Eight-CircRNA Assessment Model for Predicting Biochemical Recurrence in Prostate Cancer
Shuo Wang, Wei Su, Chuanfan Zhong, et al.
Journal of the American College of Surgeons
|
February 8, 2020
Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer
Yanghee Woo, Zhifang Zhang, Annie Yang, et al.
Page
of 18